Difference between revisions of "Profiles"
Jump to navigation
Jump to search
Line 14: | Line 14: | ||
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment Profiles=== | ===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment Profiles=== | ||
− | + | The following Profiles are open for Public Comment: | |
+ | Submit comments here: http://tinyurl.com/QIBA-Public-Comment-Form | ||
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] ''Open until September 15, 2017'' | *[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] ''Open until September 15, 2017'' | ||
*[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| QIBA MRE Profile 2017-08-15]] ''Open until September 15, 2017'' | *[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| QIBA MRE Profile 2017-08-15]] ''Open until September 15, 2017'' |
Revision as of 14:54, 15 September 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
The following Profiles are open for Public Comment:
Submit comments here: http://tinyurl.com/QIBA-Public-Comment-Form
- QIBA PET Amyloid Profile 2017-06-15 Open until September 15, 2017
- QIBA MRE Profile 2017-08-15 Open until September 15, 2017
- QIBA fMRI Profile 2017-06-19 Open until September 19, 2017
Public Comment closed:
- DWI Profile 2017-04-27 Closed on August 25, 2017
- QIBA Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening Profile 2016-06-01 (Closed Sept 2016)
- DCE-MRI Quantification 2011-12-13 (Closed Feb 2012)
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)